Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites

(2017) Alireza Badirzadeh et al.   PLoS Neglected Tropical Diseases

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines

(2017) Namit Holay et al.   Frontiers in Immunology

The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance

(2016) Ana Perea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mammalian host defense peptides and their implication on combating Leishmania infection

(2016) Zahra Abdossamadi et al.   CELLULAR IMMUNOLOGY

Enhanced paromomycin efficacy by solid lipid nanoparticle formulation againstLeishmaniain mice model

(2016) M. Heidari-Kharaji et al.   PARASITE IMMUNOLOGY

Leishmaniasis and various immunotherapeutic approaches

(2016) Y. TASLIMI et al.   PARASITOLOGY

Defensins: The Case for Their Use against Mycobacterial Infections

(2016) Haodi Dong et al.   Journal of Immunology Research

EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice

(2015) Samira Seif et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation

(2015) Pujarini Dutta et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Defensins: “Simple” antimicrobial peptides or broad-spectrum molecules?

(2015) Meggy Suarez-Carmona et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Production of in-vitro refolded and highly antigenic SAG1 for development of a sensitive and specific Toxoplasma IgG ELISA

(2015) Mojgan Allahyari et al.   JOURNAL OF IMMUNOLOGICAL METHODS

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant <i>Leishmania major</i> Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite

(2015) Somayeh Sadeghi et al.   KOREAN JOURNAL OF PARASITOLOGY

The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases

(2015) Angélique Lewies et al.   MOLECULES

Antimicrobial Peptides in Human Sepsis

(2015) Lukas Martin et al.   Frontiers in Immunology

The role of IL-4 and IL-13 in cutaneous Leishmaniasis

(2014) Ramona Hurdayal et al.   IMMUNOLOGY LETTERS

Skin Electroporation of a Plasmid Encoding hCAP-18/LL-37 Host Defense Peptide Promotes Wound Healing

(2014) Lars Steinstraesser et al.   MOLECULAR THERAPY

Host defense peptides: front-line immunomodulators

(2014) Sarah C. Mansour et al.   TRENDS IN IMMUNOLOGY

Recent progress concerning CpG DNA and its use as a vaccine adjuvant

(2013) Hidekazu Shirota et al.   Expert Review of Vaccines

IL-4 Attenuates Th1-Associated Chemokine Expression and Th1 Trafficking to Inflamed Tissues and Limits Pathogen Clearance

(2013) Christopher A. Lazarski et al.   PLoS One

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis

(2013) Noushin Saljoughian et al.   PLoS Neglected Tropical Diseases

Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate

(2013) Sara Dabirian et al.   PLoS Neglected Tropical Diseases

Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection

(2013) Yegnasew Takele et al.   PLoS Neglected Tropical Diseases

Host defense peptides: An alternative as antiinfective and immunomodulatory therapeutics

(2012) Annia Alba et al.   BIOPOLYMERS

Antimicrobial Peptide Action on Parasites

(2012) Marc Torrent et al.   CURRENT DRUG TARGETS

Tissue damage and immunity in cutaneous leishmaniasis

(2012) S. Nylén et al.   PARASITE IMMUNOLOGY

Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani

(2011) Bidyut Purkait et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of BMAP-28 Antimicrobial Peptides on Leishmania major Promastigote and Amastigote Growth: Role of Leishmanolysin in Parasite Survival

(2011) Miriam A. Lynn et al.   PLoS Neglected Tropical Diseases

Amphotericin B inhibits entry of Leishmania donovani into primary macrophages

(2010) Yamuna Devi Paila et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

IL-6: Regulator of Treg/Th17 balance

(2010) Akihiro Kimura et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Vaccines to combat the neglected tropical diseases

(2010) Jeffrey M. Bethony et al.   IMMUNOLOGICAL REVIEWS

Arginase: an emerging key player in the mammalian immune system

(2009) Markus Munder   BRITISH JOURNAL OF PHARMACOLOGY

Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature

(2009) Ifeoma Okwor et al.   Immunotherapy

Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration

(2009) Ahmed Mudawi Musa et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense

(2009) Yuping Lai et al.   TRENDS IN IMMUNOLOGY

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

(2008) Abhishek Das et al.   JOURNAL OF EXPERIMENTAL MEDICINE

APD2: the updated antimicrobial peptide database and its application in peptide design

(2008) Guangshun Wang et al.   NUCLEIC ACIDS RESEARCH

Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies

(2008) Azam Bolhassani et al.   VACCINE

Antimicrobial activity of truncated α-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges

(2007) Fionnuala T. Lundy et al.   MOLECULAR IMMUNOLOGY